Instylla Announces Completion of $30MM EQUITY Financing

Secured financing advances Instylla's clinical trials and commercialization readiness BEDFORD, Mass., Aug. 15, 2023 -- (Healthcare Sales & Marketing Network) -- Instylla, Inc., a privately held company developing next-generation liquid embolics for per... Devices, Interventional, Venture Capital Instylla , Embrace HES, embolization, liquid embolics, embolotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news